South Africa should override patent on key HIV medicine after widespread stock out problem
South Africa should override patent on key HIV medicine after widespread stock out problem
- After six months of persistent supply problems with the key HIV medicine lopinavir/ritonavir (LPV/r), Médecins Sans Frontières (MSF) urged the South African government to put the public’s health first and
- After six months of persistent supply problems with the key HIV medicine lopinavir/ritonavir (LPV/r), Médecins Sans Frontières (MSF) urged the South African government to put the public’s health first and